Over the last several decades, considerable research has focused on the development of cell encapsulation technology to treat a number of diseases, especially type 1 diabetes. One of the key advantages of cell encapsulation is that it permits the use of xenogenic tissue, particularly animal-derived cell lines. This is an attractive idea, because it circumvents the issue of a limited human organ supply. Furthermore, as opposed to whole islets, cell lines have a better proliferative capacity and can easily be amplified in culture to provide an endless supply of uniform cells. We have previously described a macroencapsulation device for the immunoisolation of insulin-secreting β-cells. The aim of this work was to optimize the viability and insulin secretion of cells encapsulated within this device. Specifically, the effects of cell packing density and device membrane configuration were investigated. The results indicated that cell density plays an important role in the secretory capacity of the cells, with higher cell density leading to increased insulin secretion. Increasing the transport area of the capsule by modifying the membrane configuration also led to an improvement in the insulin output of the device.
INTRODUCTION
that retain their ability to perform specialized functions (26) . These cell lines have proved useful in treating several ailments. For example, rodent β-cell lines ex-Over the last several decades, considerable research has focused on the development of cell encapsulation pressing the simian virus-40 (SV-40) T-cell antigen oncoprotein have been established that exhibit a well-technology to treat a number of diseases (3,4, 16, 21, 23, 24, 39) . In this approach, therapeutic cells are isolated differentiated and stable phenotype. These cells can be easily expanded in culture and demonstrate robust insu-from the host immune system by a selectively permeable membrane. Low molecular weight substances such as lin production and normal glucose-stimulated insulin secretion (GSIS) (7) . When transplanted into rats with oxygen, nutrients, therapeutic proteins, and cellular waste are exchanged freely across the membrane, while streptozotocin-induced diabetes, euglycemia was promptly restored and maintained for up to 5 months (31) . larger immune components are excluded. Thus, transplanted cells could potentially function without the use
We have previously described a macroencapsulation device for the immunoisolation of insulin-secreting βof immunosuppressants.
One of the key advantages of immunoisolation tech-cells (18) . The biocapsule, which consists of an aluminum tube with an aluminum oxide membrane, can easily nology is that it permits the use of xenogenic tissue. Xenogenic tissues, particularly animal-derived cell lines, be created in a few hours using a simple two-step anodization process. Earlier work has shown that these bio-are an attractive option for the treatment of diseases because they circumvent the nontrivial issue of a limited capsules are relatively biocompatible in vivo (19) . Furthermore, it has been demonstrated that they are human organ supply (5). Because many primary cells replicate poorly in culture, investigators often alter the effective as immunoisolation devices under in vitro conditions, and are capable of supporting insulin-secreting original versions and thus establish immortal cell lines 766 LA FLAMME ET AL. cells (18) . However, for the successful implementation like pattern around the circumference of the device, with an approximate open pore area of 0.60 cm 2 . of a macroencapsulation device, the viability and functional performance of encapsulated cells must be opti-Cell Culture mized. Two significant parameters to consider are cell packing density and device arrangement. The impor-MIN6 insulinoma cells, which express the SV-40 Tcell antigen oncoprotein, were a kind gift from Dr. Lara tance of understanding the effects of packing density in a macroencapsulation device has been highlighted in the Leoni at the University of Illinois Chicago. This cell line was chosen because it has been shown to secrete insulin literature; however, little systematic characterization has been carried out (21, 35) . In this work, the influence of in response to physiological glucose levels (13, 30, 36) . Additionally, glucose transport, glucose uptake, glucose cell packing density and membrane configuration on the viability and functional performance of encapsulated βmetabolism, and GSIS by MIN6 cells mimic that of normal islets (14). The cells were cultured in 75-cm 2 flasks cells were examined.
with Dulbecco's modified Eagle medium (DMEM) MATERIALS AND METHODS (ATCC, Manassas, VA) supplemented with 15% fetal Membrane Fabrication bovine serum and 1% penicillin/streptomycin. The cells were grown to confluence and then harvested for use. The fabrication of nanoporous alumina capsules, illustrated in Figure 1A , has been described in detail else-All experiments were done with MIN6 cells at passages 45-48. where (11, 18, 19) . Briefly, an aluminum tube (99.9% pure, Alfa-Aesar, Ward Hill, MA) with starting length, Encapsulation Procedure outer diameter, and wall thickness of 2.5 cm, 6.35 mm, and 710 µm, respectively, was cleaned and precoated MIN6 cells were grown to confluence in a 75-cm 2 tissue culture flask and then harvested using 0.25% tryp-with resist on the outer surface to protect it from being anodized during the subsequent fabrication steps. The sin-EDTA. After spinning the cells down on a centrifuge at 800 × g, they were resuspended in 1 ml of culture inner surface of the tube was then anodized with a voltage of 60 V in a solution of 0.25 M oxalic acid for 8 h.
medium, and the density of this cell suspension was determined by staining the cells with trypan blue and then The resulting thin film of aluminum oxide (AO) was then etched away using a solution of 4 wt% chromic counting with a hemacytometer. The density of the cell suspension was adjusted to the desired value by adding acid and 8 vol% phosphoric acid, leaving a pretextured aluminum surface necessary for the formation of an or-back culture medium. Prior to encapsulation, MIN6 cells were embedded in ganized nanoarray of pores during the second anodization step. The inner side of the tube was anodized a a collagen matrix (Type 1 rat tail collagen, BD-Biosciences, Franklin Lakes, NJ), using a collagen concentra-second time under the same conditions, resulting in a layer of nanoporous alumina that serves as the final tion of 0.6 mg/ml. Once the cells were mixed into the matrix material, approximately 650 µl of the collagen/ membrane. Depending on the desired membrane configuration, a small area of the resist on the outer surface of cell solution was placed into a capsule (previously sterilized by autoclaving) using an Eppendorff pipette. The the tube was removed, and the aluminum layer was etched away with a solution of 10 wt% HCl and 0.1 M ends of the capsules were sealed with sterilized rubber endcaps. The loaded capsules were then placed in one CuCl 2 . Finally, a superficial amorphous barrier layer of alumina was etched away using 10 vol% phosphoric well of a six-well tissue culture plate, covered with cell culture medium, and placed in an incubator at 5% CO 2 acid, exposing the underlying nanoporous alumina. The resulting membranes display a highly ordered array of and 37°C. honeycomb-shaped pores and a tight pore size distribu-Insulin Secretion Studies tion ( Fig. 1B) (18) . The mean pore size of these membranes was approximately 75 nm; however, it should be
To determine the functionality of encapsulated cells, we tested their ability to respond to a glucose challenge. noted that other pore sizes can be obtained by changing the anodization voltage, with a correlation of ϳ1.29 nm/ MIN6 cells were embedded in a collagen matrix as described in the previous section and then loaded into a V (11, 18) . Because the membranes are actually incorporated into the tube, they are strong enough for easy han-capsule with a nominal pore size of 75 nm. Packing densities of 5 × 10 5 , 10 6 , and 2 × 10 6 cells/ml were used in dling and use, withstanding up to 32.6 MPa before failure (15) . Two different membrane configurations were capsules with only one membrane window; packing densities of 2 × 10 6 , 5 × 10 6 , and 10 7 cells/ml were used in used in these experiments (Fig. 1C ). The original design consisted of one membrane window, with an approxi-capsules with the modified membrane configuration. The loaded capsule was incubated in glucose-free me-mate open pore area of 0.10 cm 2 ; the modified design consisted of six membrane windows arranged in a brick-dium overnight to bring down the cellular insulin secre- tion to basal levels. On the day of the experiment, the rate (data not shown). No significant changes were found. The temperature was maintained at 37°C by plac-loaded capsule was placed in a perfusion chamber and warm culture medium (37°C, 25 mM glucose) was ing the flow chamber on a hotplate that was regulated by a thermocouple. Samples of 100 µl were taken di-pumped through the chamber at a flow rate of 26.6 ml/ min via a peristaltic pump. A diagram of this setup is rectly from the perfusion chamber at regular intervals and replaced with 100 µl of fresh medium. The samples shown in Figure 2 . Preliminary studies were done to test how the insulin release profile changed with perfusion were stored at −20°C until they were assayed. Experi- Figure 2 . Left: the perifusion setup used for the insulin secretion studies. The capsule is placed inside the perifusion chamber and is perifused with warm culture medium via a peristaltic pump. The temperature of the system is maintained at 37°C by placing the apparatus on a hotplate that is regulated by a thermocouple. Samples are taken at regular time intervals directly from the perifusion chamber, and replaced with fresh medium. Right: picture of the capsule inside the flow chamber. The capsule rests on small holders that are welded inside the chamber.
ments were run for 240 min at 3, 5, and 7 days posten-with serum-free cell culture medium. A solution of 10 µM CMFDA was prepared, and the gels were immersed capsulation. In between runs, the capsules were returned to a six-well plate, covered in cell culture medium, and in the dye solution and incubated at 37°C for 30 min. Due to their thickness, the gels were rinsed again and placed in an incubator at 5% CO 2 and 37°C. Each experiment was performed in triplicate.
incubated in serum-free medium for an additional 30 min in order to allow the free dye to diffuse out of the Quantification of Insulin Secretion collagen. After another rinsing step, the gels were immersed in a 500 nM POPO-3 solution for 10 min. Once The insulin content of all samples was measured by using an Ultrasensitive Mouse Insulin ELISA (Mer-stained, the gels were rinsed a final time with medium and placed on glass microscope slides for analysis. codia, Winston Salem, NC). Briefly, microwells coated with anti-insulin antibodies were loaded with 50 µl of The organization of encapsulated MIN6 cells was studied for both the original and modified membrane standards or samples and 50 µl of peroxidase-conjugated anti-insulin antibodies and incubated for 2 h. A washing configurations. For the studies on cells encapsulated in the former, an additional staining step was required in step removed unbound enzyme-labeled antibody, and then 200 µl of 3,3′,5,5′-tetramethylbenzidine was added order to determine the orientation of the cells with respect to the membrane window. In this case, before to each microwell. After a 30-min incubation, 50 µl sulfuric acid was added to each well to stop the reaction.
removing the cells from the capsule, Alexa Fluor was used to mark the area of collagen directly behind the The colorimetric endpoint was read spectrophotometrically.
membrane. Briefly, a small droplet of 10 µM Alexa Fluor 633 was placed directly on the membrane, and this Cell Viability and Organization was allowed to incubate at room temperature for 10 min, permitting enough time for the droplet to pass through In addition to insulin secretion, the viability and the distribution and organization of encapsulated MIN6 the membrane and stain the surface of the collagen matrix. After 10 min, the reaction was quenched using 1× cells were also observed. Live cells were stained using 5-chloromethylfluorescein diacetate (CMFDA) (Molec-Tris-buffered saline. The gels were then removed from the capsule and stained for live and dead cells as pre-ular Probes, Carlsbad, CA), and dead cells were stained with POPO-3 (Molecular Probes). The staining proce-viously described.
Confocal microscopy was used to ascertain the via-dure was as follows. Cell-loaded gels were removed from the capsules and placed into one well of a six-well bility and organization of encapsulated MIN6 cells with varying packing densities for both types of capsules. The tissue culture plate. The gels were rinsed three times excitation sources used for CMFDA, POPO-3, and Alexa Fluor 633 had wavelengths of 488, 543, and 633 nm, respectively. The wavelengths of the emitted light were 517, 570, and 647 nm, respectively. Z-stacks ranging anywhere from 30 to 52 slices thick were obtained, with a z-spacing of 6.95 µm. Image J software was used to quantify the cells.
Statistics
A two-factor repeated measures ANOVA was carried out using SigmaStat software to assess the differences in insulin secretion with respect to cell density and time.
RESULTS

Influence of Cell Packing Density on Insulin Secretion
In these experiments, the effects of three different packing densities (5 × 10 5 , 10 6 , and 2 × 10 6 cells/ml) on the GSIS of encapsulated MIN6 cells (a step increase from 0 to 25 mM glucose) were investigated. Capsules with the original membrane configuration were initially used for these studies. As previously mentioned, MIN6 cells exhibit glucose-stimulated insulin release similar to that of isolated islets (14). Furthermore, earlier studies have indicated that about 250-1,000 islets are required to restore normoglycemia in diabetic mice (6,10). The number of β-cells placed in each device for these studies was chosen in accordance with these values, assuming about 800 β-cells to be equivalent to one islet. Figure  3 demonstrates the insulin release profiles for all three densities after 3, 5, and 7 days postencapsulation. Clearly, MIN6 cells encapsulated with the highest packing density exhibited the most insulin secretion. Interestingly, there was a much larger jump in insulin secretion between 10 6 and 2 × 10 6 cells/mlL than between 5 × 10 5 and 10 6 cells/ml. Figure 4 compares the insulin release profiles from capsules with low (0.10 cm 2 ) and high (0.60 cm 2 ) mem- of 2 × 10 6 cells/ml. The results show that increasing the ted on the y-axis is cumulative. The cell densities used were 5 × 10 5 (diamonds), 10 6 (squares), and 2 × 10 6 (triangles). *Stamembrane area led to a twofold increase in insulin tistical significance between cell densities 2 × 10 6 and 5 × 10 5 , output. and between 2 × 10 6 and 10 6 . No statistical difference was With these results in mind, the influence of cell denfound between cell densities of 10 6 and 5 × 10 5 . sity on the functional performance of encapsulated cells was further investigated in the context of this modified membrane configuration. Cell densities of 2 × 10 6 , 5 × Organization and Distribution of MIN6 Cells 10 6 , and 10 7 cells/ml were used. Figure 5 demonstrates that increasing density led to increased insulin output, in An understanding of the organization and viability of β-cells within the device, and how these properties accordance with the previous results. Once again, the amount of insulin secreted did not seem to increase pro-change with respect to other parameters such as cell density and transport area, may give some insight into how portionally with the increase in cells. these factors affect cell behavior. Cell-loaded collagen bling islets were present that were not observed for cells encapsulated at the lower packing densities (Fig. 7) . gels were removed from the capsules after 1, 3, 5, or 7 days in culture, and stained with CMFDA for live cells DISCUSSION and POPO-3 for dead cells. Figure 6 shows the distribution of live and dead cells at 7 days postencapsulation This work focused on the development of a cell macroencapsulation device for the treatment of diseases, for 5 × 10 5 cells/ml in a capsule with low transport area and 10 7 cells/ml in a capsule with high transport area. specifically type 1 diabetes. Many approaches for creating such a bioartificial pancreas involve the encapsula-These graphs are representative of the distribution of live and dead cells throughout the collagen matrix, with tion of intact islets of Langerhans (20, 22, 28, 37, 38) . However, the low availability of human donors, as well the number of cells plotted on the y-axis, and the relative distance of the cells from the membrane with respect to as the limited proliferative capacity of islets, has restricted the widespread use of islet cell transplantation the total thickness of the gel on the x-axis. Interestingly, the amount of dead cells did not increase with increasing (8, 9, 17, 21, 29, 36) . The use of β-cell lines could alleviate some of these problems. These cells exhibit secretory distance from the membrane; instead, their dispersal seemed to mimic that of the live cells. This general pat-responses similar to those of normal islets (7,14,21), and can be easily amplified in culture under well-defined tern was the same irrespective of packing density or membrane configuration.
Increasing the Transport Area
conditions, offering an attractive alternative to the largescale isolation of islets. It was also observed that increased cell packing density resulted in diminished thickness of the collagen ma-
The literature has indicated the importance of understanding the role of packing density in a practical encap-trix. Average gel thicknesses were approximately 350 µm for the cell densities up to 2 × 10 6 cells/ml and then sulation device (21, 35) . Studies with islets cultured on 2D surfaces have shown that culture density affects the decreased to approximately 250-280 µm for cell densities of 5 × 10 6 and 10 7 . Subsequent imaging revealed viability and functional performance of the islets (33) . Similarly, the packing density of encapsulated β-cells in that at the higher densities, small clusters of cells resem-even naked islets with large diameters may develop necrotic cores (4). The transport limitation of oxygen to encapsulated islets is estimated to be around 150-200 µm from the membrane. On the other hand, low packing densities may also present problems. Cell-to-cell contacts have been shown to play an important role in the development and maintenance of the β-cell phenotype. For example, interactions between β-cells contribute to the regulation of proliferation and apoptosis (25). Perhaps most important is that intracellular interactions are essential for normal insulin secretion (12) .
The effects of cell densities ranging from 5 × 10 5 to 2 × 10 6 cells/ml on glucose-stimulated insulin secretion were initially studied. These results are reported in Figure 3 . The highest cell density resulted in the most insulin output; further, the relationship between insulin release and cell density was nonlinear, suggesting that some factor besides the increased number of cells was contributing to the enhanced insulin secretion. As previously mentioned, the interactions between encapsulated β-cells help to mediate insulin secretion. Therefore, the markedly higher insulin secretion displayed by the most densely packed cells is due to both the larger number of β-cells, as well as increased intercellular communications.
Increasing the transport area of the membrane by modification of the device arrangement also led to improved insulin output. This is due not only to the additional area available for insulin transport, but also to the enhanced access of oxygen, nutrients, and glucose to the cells, which results in greater cell viability and insulin secretion. Figure 4 compares the insulin release profiles from capsules with low (0.10 cm 2 ) and high (0.60 cm 2 ) membrane areas, for a cell density of 2 × 10 6 cells/ml at 5 days postencapsulation. The results show that increasing the membrane area led to a twofold increase in insulin output. This increase is less than expected, considering the sixfold increase in transport area. This is likely because the cells are not evenly dispersed throughout the gel; rather, they appear to be more heavily concen- (Fig. 6 ). This may be due to the fact that cells settle (B) 5 days, and (C) 7 days. Insulin release plotted on y-axis is to one side before the collagen matrix is completely a cumulative value. Densities used were 2 × 10 6 (diamonds), 5 × 10 6 (squares), and 10 7 (triangles). *Statistical significance cured, and/or the result of an accumulation of cells on between cell densities 10 7 and 2 × 10 6 , and between 10 7 and 5 one side as they migrate towards each other in the ma-× 10 6 . No statistical difference was found between cell densitrix. Therefore, even though the transport area is higher, ties of 5 × 10 6 and 2 × 10 6 . #Statistical significance between some cells are still too far removed from a membrane cell densities of 10 7 and 2 × 10 6 only. window to get adequate oxygen and nutrients.
The influence of higher packing densities (2 × 10 6 , 5 × 10 6 , and 10 7 cells/ml) on the functional performance a 3D configuration is expected to play an important role in their behavior. First, packing density relates directly of encapsulated cells was further investigated in the context of the modified membrane configuration. Figure 5 to the ability of the encapsulated cells to receive adequate oxygenation. Thus, a packing density that is too demonstrates that increasing density led to enhanced insulin output, with a nonlinear increase in insulin secre-high might lead to hypoxia-induced death (HID); in fact, tion with respect to packing density. Subsequent imaging certainly led to inadequate oxygenation and nutrition of some of the cells, particularly ones that were further of the encapsulated cells with a confocal microscope demonstrated the presence of islet-like aggregates at cell away from a membrane. The simplest solution to this issue could be to use a thinner diameter aluminum tube densities of 5 × 10 6 and 10 7 that are not presented by lower densities (Fig. 7) . It has been shown that MIN6 or a flat design in order to maximize the transport area to volume ratio. In vivo, hypoxic cell loss could be mini-cells, after several days in culture, begin to form clusters, termed "pseudoislets" (1,34). Pseudoislets are mized by prevascularization of the device prior to cell loading, which could be achieved through the use of a formed primarily through aggregation of individual cells rather than proliferation (25); this phenomenon is most tapered pore design (32) or the incorporation of growth factors and cellular agents that induce and maintain neo-certainly the cause of the observed collagen contraction. Contraction of a collagen matrix by embedded cells has vascularization (27) . Another reason for the drop in insulin output could be due to the lack of cell-cell con-been previously observed with islet cells as well as a number of other cell types including fibroblasts and he-tacts. Interactions between β-cells play an important role in a number of β-cell functions such as proliferation, patocytes (2). Further, previous work has shown that insulin secretion from MIN6 pseudoislets was approxi-cell death, and, most importantly, insulin secretion. It is expected that increasing cell packing density, as well as mately 2.5-fold higher than MIN6 monolayers (12) . These data support the hypothesis that the marked in-preculturing MIN6 cells into pseudoislets prior to encapsulation, will result in an overall improvement in insulin crease of insulin output with cell density is due not only to the increased number of cells but is further enhanced output. by interactions between cells.
CONCLUSIONS For both membrane configurations, it was noted that the total amount of insulin secreted dropped over the Many efforts have been made over the last several decades to develop a xenotransplantation system for the course of the 7-day study period. This is believed to be due to several reasons. First, the diffusion limitations treatment of type 1 diabetes. Lasting success has been limited for a number of reasons, including lack of bio-associated with a device as big as the one described here work is applicable to the development of other types of encapsulation devices.
The results indicated that cell density plays an important role in the secretory capacity of the cells, with higher cell density leading to increased insulin secretion. This is believed to be due, at least in part, to the formation of islet-like aggregates of cells. Cell-cell contacts have been shown in previous studies to enhance the secretion of insulin from β-cells (12, 25) . Increasing the transport area of the capsule by modifying the membrane configuration also led to augmented insulin output. This is due not only to the increased available area for insulin transport, but also to the fact that oxygen and other nutrients, particularly glucose, have greater access to the cells and thus facilitate greater cell viability and insulin secretion from the cells.
It is expected that culturing β-cells into pseudoislets prior to encapsulation will result in improved cell functionality. Furthermore, a number of modifications to the capsule itself will be considered in order to secure the ability of this device to support and maintain viable, functional β-cells. Specifically, the transport area to volume ratio of the capsule should be maximized in order to optimize the supply of nutrients, oxygen, and glucose to the encapsulated cells. Considering the diffusion limitations of oxygen, it may be desirable to achieve this goal with the use of a smaller diameter aluminum tube or perhaps a flat design, in addition to increasing the membrane area.
